Ignite Creation Date:
2025-12-24 @ 7:22 PM
Ignite Modification Date:
2026-01-01 @ 11:59 PM
Study NCT ID:
NCT00828503
Status:
UNKNOWN
Last Update Posted:
2012-09-03
First Post:
2009-01-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients
Sponsor:
Marcus Saemann
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
EudraCT: 2008-004745-28
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None